What will happen to value-based care under the Donald Trump presidency?
President-elect Donald Trump's healthcare plan repeals the Affordable Care Act and would target the value-based initiatives along with it. According to a HealthData Management report, there has been bipartisan support for change in healthcare reimbursement and adding a value-based component as an alternative to fee-for-service.
The value-based payment models, such as ACOs and bundled payments, have had mixed results so far. CMS heads multiple initiatives, including the Pioneer ACOs and the Comprehensive Care for Joint Replacements program, implemented to reduce healthcare expenditures.
The Republican Party also holds both houses of Congress, which could slow any progress toward value-based care, Premier's Blair Childs said in the HealthData Management report. GOP lawmakers have been concerned about the "pace of change" and whether government agencies should require participation in CMS' demonstration projects.
The Center for Medicare and Medicaid Innovation is tasked with moving value-based care initiatives forward, but Congress could reduce its role and requirements for participation could change.
However, Mr. Childs argued hospitals and healthcare providers will still move toward value-based care due to the increased aging population and need to curtail rising healthcare spending.
Both Mr. Childs and Advisory Board's Eric Cragun, who also contributed to the article, believe the ACA won't be repealed despite Mr. Trump and the GOP's insistence otherwise.
More articles on healthcare:
10 key trends in physician executive pay—C-suite reaches $499k
The number of Medicare-certified ASCs in all 50 states per 1k persons
IT decision makers in healthcare reveal biggest challenges, focus areas
© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
- Participants race to increase colon cancer awareness during 2017 Greater Chattanooga Rump Run 5K and Fun Walk: 4 takeaways
- US woman dies from superbug resistant to 26 antibiotics — 8 things to know
- Healthcare nanotechnology market to grow at a CAGR above 12% till 2024
- American Anesthesiology to exhibit at ASA's Practice Management 2017: 3 things to know
- Gastroenteropancreatic neuroendocrine tumor patients utilize combination therapy: 5 study insights